What's New

Last Posted: Nov 06, 2020

• Joint and interactive effects between health comorbidities and environmental exposures in predicting amyotrophic lateral sclerosis.
  Bellavia Andrea et al. International journal of hygiene and environmental health 2020 Oct 231113655
• Genome-wide Meta-analysis Finds the ACSL5-ZDHHC6 Locus Is Associated with ALS and Links Weight Loss to the Disease Genetics.
  Iacoangeli Alfredo et al. Cell reports 2020 Oct 33(4) 108323
• Study on sleep-wake disorders in patients with genetic and non-genetic amyotrophic lateral sclerosis.
  Sun Xiaohan et al. Journal of neurology, neurosurgery, and psychiatry 2020 Oct
• Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases.
  Quinn Colin et al. Continuum (Minneapolis, Minn.) 2020 Oct 26(5) 1323-1347
• ALS Genetics: Gains, Losses, and Implications for Future Therapies.
  Kim Garam et al. Neuron 2020 Sep
• Clinical and Molecular Landscape of ALS Patients with SOD1 Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study.
  Bernard Emilien et al. International journal of molecular sciences 2020 Sep 21(18)
• The complex relationship between genotype, pathology and phenotype in familial dementia.
  Kwok John B et al. Neurobiology of disease 2020 Sep 105082
• Amyotrophic lateral sclerosis in the Faroe Islands - a genealogical study.
  Johansen Malan et al. Amyotrophic lateral sclerosis & frontotemporal degeneration 2020 Sep 1-5
• Opening the door to gene therapy for ALS
  H Stower, Nature Medicine, August 7, 2020
• Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management.
  Roggenbuck Jennifer et al. Clinics in laboratory medicine 2020 Sep 40(3) 271-287
• ALS Research Notification for Clinical Trials and Studies
  CDC/ATSDR, July 2020
• Evaluation of Vertical Ground Reaction Forces Pattern Visualization in Neurodegenerative Diseases Identification Using Deep Learning and Recurrence Plot Image Feature Extraction.
  Lin Che-Wei et al. Sensors (Basel, Switzerland) 2020 Jul 20(14)
• SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS.
  Mueller Christian et al. The New England journal of medicine 2020 Jul 383(2) 151-158
• Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
  Miller Timothy et al. The New England journal of medicine 2020 Jul 383(2) 109-119
• Burden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort.
  Scarlino Stefania et al. International journal of molecular sciences 2020 May 21(9)